Shulman Rayzel M, O'Gorman Clodagh S, Palmert Mark R
Division of Endocrinology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, Canada M5G 1X8.
Int J Pediatr Endocrinol. 2010;2010. doi: 10.1155/2010/536957. Epub 2010 Sep 22.
Our objective was to determine the impact of telemedicine (TM) interventions on the management of type 1 diabetes (T1DM) in youth. We performed a systematic review of randomized trials that evaluated TM interventions involving transmission of blood glucose data followed by unsolicited scheduled clinician feedback. We found no apparent effect of the TM interventions on hemoglobin A1c (HbA1c), severe hypoglycemia, or diabetic ketoacidosis. The limited data available on patient satisfaction, quality of life, and cost also suggested no differences between groups. It is unlikely that TM interventions, as performed in the assessed studies, had a substantial effect on glycemic control or acute complications. However, it remains possible that there are other benefits of TM not adequately reported, that newer TM strategies may be more effective and that interventions may benefit subgroups of youth, such as those with the poor glycemic control, adolescents, or those living in remote areas.
我们的目标是确定远程医疗(TM)干预措施对青少年1型糖尿病(T1DM)管理的影响。我们对随机试验进行了系统综述,这些试验评估了涉及传输血糖数据并随后由临床医生主动提供定期反馈的TM干预措施。我们发现TM干预措施对糖化血红蛋白(HbA1c)、严重低血糖或糖尿病酮症酸中毒没有明显影响。关于患者满意度、生活质量和成本的现有有限数据也表明两组之间没有差异。在所评估的研究中实施的TM干预措施不太可能对血糖控制或急性并发症产生实质性影响。然而,TM可能存在其他未充分报道的益处,新的TM策略可能更有效,并且干预措施可能使青少年亚组受益,例如血糖控制不佳的青少年、青少年或居住在偏远地区的青少年。